Interleukin-9 and T helper type 9 cells in rheumatic diseases
- 21 July 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 185 (2) , 125-132
Abstract
Summary: Interleukin (IL)-9 is a 28-30 kDa monomeric glycosylated polypeptide belonging to the IL-7/IL-9 family of proteins that bind to a composite receptor consisting of the private receptor IL-9R and the IL-2 receptor, gamma (IL-2RG), a common gamma subunit shared by the receptors of many different cytokines. The IL-9R is expressed widely and IL-9 impacts a number of effector cells, such as effector T cells, B cells, innate lymphoid cells, mast cells, polymorphonuclear cells, epithelial cells and smooth muscle cells, playing an important role in regulating inflammatory immunity. The critical role of IL-9 in promoting cellular and humoral immune responses makes it an important focus of potential therapeutic interventions. Recently, a defined subset of T helper type cells, Th9 cells, has been identified by the potent production of IL-9. The involvement of the Th9 cell subset has been described in many types of inflammatory diseases, namely atopic diseases, helminth infections, experimental autoimmune encephalomyelitis and ulcerative colitis. In this review, we summarize the IL-9 biological activities, highlighting roles for IL-9 and Th9 cells in rheumatoid and psoriatic arthritis, systemic vasculitis, systemic lupus erythematosus and systemic sclerosis.Keywords
Funding Information
- Ministero dell'Istruzione, della Università e della ricerca scientifica from Italy.
This publication has 69 references indexed in Scilit:
- Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of PsoriasisPLOS ONE, 2013
- The Th17/IL-23 Axis and Natural Immunity in Psoriatic ArthritisInternational Journal of Rheumatology, 2012
- Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen‐specific B cells induces enhanced CD4+ T helper type 1 subset differentiationImmunology, 2011
- A Brief History of IL-9The Journal of Immunology, 2011
- Proteoglycan‐induced arthritis and recombinant human proteoglycan aggrecan G1 domain–induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritisArthritis & Rheumatism, 2011
- Differentiation of Effector CD4 T Cell PopulationsAnnual Review of Immunology, 2010
- Th17 and Th1 T-Cell Responses in Giant Cell ArteritisCirculation, 2010
- IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38α-dependent pathwayJournal of Leukocyte Biology, 2009
- IL-33–activated dendritic cells induce an atypical TH2-type responseJournal of Allergy and Clinical Immunology, 2009
- T cells in rheumatoid arthritisArthritis Research & Therapy, 2008